MétaCan
Menu
Back to cohort
Record W2592016869 · doi:10.1194/jlr.r075556

Therapeutic potential of nuclear receptor agonists in Alzheimer's disease

2017· review· en· W2592016869 on OpenAlex
Miguel Moutinho, Gary E. Landreth

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

fundA Canadian funder is recorded on the work.
no affNo Canadian affiliation: this work is invisible to an affiliation-only frame.
No Canadian affiliation. An affiliation-only frame, the usual design, would never have seen this work. It is one of the works that make the case for inverting the frame.

Bibliographic record

VenueJournal of Lipid Research · 2017
Typereview
Languageen
FieldNeuroscience
TopicNuclear Receptors and Signaling
Canadian institutionsnot available
FundersNational Institute on AgingW. Garfield Weston FoundationWeston Brain Institute
KeywordsNeuroscienceDiseaseContext (archaeology)Nuclear receptorAlzheimer's diseaseMedicineTherapeutic approachInflammationTranscription factorBioinformaticsBiologyGeneInternal medicineGenetics

Abstract

fetched live from OpenAlex

central role and subsequently drives the dysregulation of the cytoskeletal protein, tau. The amyloid hypothesis is supported by a substantial body of scientific and clinical evidence (2). AD is typified by the progressive A deposition in the brain parenchyma as both diffuse and dense-core plaques, starting in isocortical areas, followed by limbic and allocortical structures, and finally subcortical structures (3). A peptide is generated by sequential cleavage of the amyloid precursor protein (APP) by the and secretases, yielding a heterogeneous pool of A species with different lengths, most prominently those of 40 or 42 amino acids in length. The A(1-42) species is more hydrophobic and highly self-aggregating, and is the principal species that is initially deposited in the brain of AD patients. APP can also be processed in a nonamyloidogenic pathway mediated by -secretase activity, generating a soluble APP fragment (sAPP), which is considered to have beneficial effects on neurons (4, 5). Genetically inherited familial forms of AD are caused by mutations in APP or in -secretase that favor A(1-42) generation, followed by aggregation and deposition. On the other hand, patients with "sporadic" late-onset AD, exhibit an impairment of A clearance from the brain, likely underlying the pathological A accumulation observed in this type of patient (6, 7). Thus, perturbation of A homeostasis caused by either increased production (familial AD) or impaired clearance (sporadic late-onset AD) of A peptides leads to the pathological accumulation of this peptide in the form of toxic A oligomers, disrupting synaptic function and plasticity, which is postulated to underlie the cognitive deficits observed in this disease. The deposition of A in the form of plaques results in neuritic Abstract Alzheimer's disease (AD) is characterized by an extensive accumulation of amyloid- (A) peptide, which triggers a set of deleterious processes, including synaptic dysfunction, inflammation, and neuronal injury, leading to neuronal loss and cognitive impairment. A large body of evidence supports that nuclear receptor (NR) activation could be a promising therapeutic approach for AD. NRs are ligandactivated transcription factors that regulate gene expression and have cell type-specific effects. In this review, we discuss the mechanisms that underlie the beneficial effects of NRs in AD. Moreover, we summarize studies reported in the last 10-15 years and their major outcomes arising from the pharmacological targeting of NRs in AD animal models. The dissection of the pathways regulated by NRs in the context of AD is of importance in identifying novel and effective therapeutic strategies.-Moutinho, M.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.992
Threshold uncertainty score0.985

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0020.000
Research integrity0.0000.002
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.377
GPT teacher head0.481
Teacher spread0.104 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it